TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23190713

Group type: EXPERIMENTAL
Intervention: Senofilcon A lenses
Number of subjects: 2154

Group type: COMPARATOR
Intervention: Non-senA lenses (lotrafilcon B, omafilcon A, and balafilcon A)
Number of subjects: 2154
Study: 19903183

Group type: EXPERIMENTAL
Intervention: Ustekinumab 45 mg
Number of subjects: 766

Group type: EXPERIMENTAL
Intervention: Ustekinumab 90 mg
Number of subjects: 766

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 766

Group type: EXPERIMENTAL
Intervention: Ustekinumab (both doses)
Number of subjects: 766
Study: 18780882

Group type: EXPERIMENTAL
Intervention: Multisensorial rehabilitation (20 sessions in 4 weeks)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Conventional neurodevelopmental theory-based treatment (NDT) (20 sessions in 4 weeks)
Number of subjects: 68
Study: 16029905

Group type: EXPERIMENTAL
Intervention: High-dose pergolide treatment (up to 12 mg/day)
Number of subjects: 32
Study: 11581508

Group type: EXPERIMENTAL
Intervention: 6 French diagnostic catheters
Number of subjects: 405

Group type: COMPARATOR
Intervention: 4 French diagnostic catheters
Number of subjects: 405
Study: 9846598

Group type: EXPERIMENTAL
Intervention: 10 ml cod liver oil daily
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 2.5 ml cod liver oil
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 5 ml cod liver oil
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 10 ml cod liver oil
Number of subjects: 22

Group type: COMPARATOR
Intervention: 0 ml cod liver oil (control)
Number of subjects: 22
Study: 7916073

Group type: EXPERIMENTAL
Intervention: Kangaroo mother method (KMM)
Number of subjects: 275

Group type: COMPARATOR
Intervention: Control (standard incubator care)
Number of subjects: 275
Study: 2679241

Group type: EXPERIMENTAL
Intervention: Picotamide (3 x 300 mg tablets)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (three identical tablets)
Number of subjects: 40
Study: 52131

Group type: EXPERIMENTAL
Intervention: Carbidopa/levodopa
Number of subjects: 38

Group type: COMPARATOR
Intervention: Levodopa alone
Number of subjects: 38
Study: 6249875

Group type: EXPERIMENTAL
Intervention: High-dosage antithymocyte globulin (IV regimen)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Low-dosage antithymocyte globulin (IM regimen)
Number of subjects: 67

Group type: COMPARATOR
Intervention: No antithymocyte globulin treatment
Number of subjects: 67
Study: 31498753

Group type: EXPERIMENTAL
Intervention: Combined‐modality treatment (CMT) with 2× ABVD and 20‐Gy involved‐field radiotherapy
Number of subjects: 1150

Group type: COMPARATOR
Intervention: ABVD alone
Number of subjects: 1150

Group type: EXPERIMENTAL
Intervention: CMT among PET‐2-negative patients
Number of subjects: 1150

Group type: EXPERIMENTAL
Intervention: CMT among PET‐2-positive patients
Number of subjects: 1150

Group type: EXPERIMENTAL
Intervention: CMT with Deauville score 4 cutoff for PET-2 positivity
Number of subjects: 1150

Group type: EXPERIMENTAL
Intervention: CMT
Number of subjects: 1150

Group type: COMPARATOR
Intervention: ABVD
Number of subjects: 1150
Study: 28289111

Group type: EXPERIMENTAL
Intervention: Oral antibiotic (flucloxacillin) and topical placebo
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Topical antibiotic (fusidic acid) and oral placebo
Number of subjects: 113

Group type: COMPARATOR
Intervention: Control (oral and topical placebos)
Number of subjects: 113
Study: 27264092

Group type: EXPERIMENTAL
Intervention: 5,000 IU of vitamin D3 every day (TD3)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (TP)
Number of subjects: 0
Study: 24361998

Group type: COMPARATOR
Intervention: Spongious allograft chips alone (Group I)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Spongious allograft chips mixed with bone marrow concentrate (Group II)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Computed tomography scans at 24 months
Number of subjects: 80
Study: 23618052

Group type: EXPERIMENTAL
Intervention: At Home/Chez Soi (Housing First) model
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mixed methods approach
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Implementation data
Number of subjects: 0
Study: 19941668

Group type: EXPERIMENTAL
Intervention: High-traders (n=31)
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Low-traders (n=116)
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: No-traders (n=97)
Number of subjects: 244

Group type: COMPARATOR
Intervention: Clusters comparison
Number of subjects: 244
Study: 18158082

Group type: EXPERIMENTAL
Intervention: Ezetimibe/simvastatin (E/S)
Number of subjects: 1397

Group type: COMPARATOR
Intervention: Ezetimibe
Number of subjects: 1397

Group type: COMPARATOR
Intervention: Simvastatin
Number of subjects: 1397
Study: 15347293

Group type: EXPERIMENTAL
Intervention: Papilla Base Incision (PBI)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Complete mobilization of the papilla
Number of subjects: 12
Study: 12355939

Group type: EXPERIMENTAL
Intervention: Postoperative oral administration of 5-FU followed by venous injection of MMC
Number of subjects: 0

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 0
Study: 9594473

Group type: EXPERIMENTAL
Intervention: Dual-cured resin composite
Number of subjects: 50

Group type: COMPARATOR
Intervention: Glass ionomer cement (GIC)
Number of subjects: 50
Study: 8021763

Group type: EXPERIMENTAL
Intervention: Clarithromycin, 15 mg/kg in two divided doses (n = 90)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Amoxicillin-clavulanate, 40 mg/kg in three divided doses (n = 90)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Clarithromycin (n = 80)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Amoxicillin-clavulanate (n = 82)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Clarithromycin
Number of subjects: 180

Group type: COMPARATOR
Intervention: Amoxicillin-clavulanate
Number of subjects: 180
Study: 2736023

Group type: EXPERIMENTAL
Intervention: Power Makeup Equipment (PME) installed on MODUs
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (MODUs not equipped with PME)
Number of subjects: 30
Study: 31299461

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Treatment (CBT)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Wait-list Control (WLC)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Cognitive Behavioral Treatment (CBT) and Wait-list Control (WLC)
Number of subjects: 51
Study: 28861199

Group type: EXPERIMENTAL
Intervention: Vitamin C
Number of subjects: 123

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 123
Study: 25786408

Group type: EXPERIMENTAL
Intervention: Amisulpride for 4 weeks followed by a 6-week double-blind RCT comparing continuation of amisulpride
Number of subjects: 500

Group type: COMPARATOR
Intervention: Switching to olanzapine after 4 weeks of amisulpride
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Clozapine treatment in nonremitters after switching
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Psychosocial interventions to enhance adherence in a subsequent 1-year RCT
Number of subjects: 500
Study: 23411538

Group type: EXPERIMENTAL
Intervention: Femoral nerve catheter inserted 5 cm
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Femoral nerve catheter inserted 10 cm
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Femoral nerve catheter inserted 20 cm
Number of subjects: 70
Study: 21999905

Group type: EXPERIMENTAL
Intervention: Treatment Adherence Therapy (TAT)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Treatment As Usual (TAU)
Number of subjects: 98
Study: 19552746

Group type: COMPARATOR
Intervention: Simvastatin 40 mg alone
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Anacetrapib 150 mg co-administered with simvastatin 40 mg
Number of subjects: 12
Study: 16139447

Group type: EXPERIMENTAL
Intervention: Norethisterone (NET) 1mg
Number of subjects: 25

Group type: COMPARATOR
Intervention: Dydrogesterone (DGT) 10mg
Number of subjects: 25
Study: 15123023

Group type: EXPERIMENTAL
Intervention: Active GSR biofeedback training (n = 10)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Sham control biofeedback (n = 8)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Between-group comparison
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Correlation with biofeedback performance
Number of subjects: 18
Study: 11304904

Group type: EXPERIMENTAL
Intervention: warfarin and bucolome (300 mg once a day)
Number of subjects: 55

Group type: COMPARATOR
Intervention: warfarin alone
Number of subjects: 55
Study: 9715781

Group type: EXPERIMENTAL
Intervention: Transdermal estradiol-17beta (E2)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 30
Study: 7845815

Group type: EXPERIMENTAL
Intervention: Steroid-eluting active fixation lead
Number of subjects: 24
Study: 2599657

Group type: EXPERIMENTAL
Intervention: Laterally condensed gutta‐percha
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Thermoplasticized gutta‐percha with sealer
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Thermoplasticized gutta‐percha without sealer
Number of subjects: 120
Study: 1092617

Group type: EXPERIMENTAL
Intervention: Dextran 70 (Macrodex) - 500 ml at operation and 500 ml on the first postoperative day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dextran 70 (Macrodex)
Number of subjects: 0
Study: 31107929

Group type: EXPERIMENTAL
Intervention: Split bone technique with autologous bone blocks
Number of subjects: 164

Group type: COMPARATOR
Intervention: Control group (implants inserted without any augmentation procedures)
Number of subjects: 164
Study: 28126706

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups (Sertraline and Placebo)
Number of subjects: 30
Study: 26900251

Group type: EXPERIMENTAL
Intervention: Bimodal stimulation (CI + contralateral hearing aid)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Unilateral CI (CI only)
Number of subjects: 39
Study: 23608801

Group type: EXPERIMENTAL
Intervention: Modified group (paralleled clipping of rectal ligament, 48 patients)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Traditional group (44 patients)
Number of subjects: 92
Study: 20599325

Group type: EXPERIMENTAL
Intervention: HF-rTMS
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sham-controlled HF-rTMS
Number of subjects: 24
Study: 19384216

Group type: EXPERIMENTAL
Intervention: FFR‐rFVIIa (4 x 400 microg/kg)
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: FFR‐rFVIIa (various doses)
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: FFR‐rFVIIa
Number of subjects: 214

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 214
Study: 17479208

Group type: EXPERIMENTAL
Intervention: Oral Mg citrate 300 mg/day (group A)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Untreated HF patients (group B)
Number of subjects: 133
Study: 16020987

Group type: EXPERIMENTAL
Intervention: Voice therapy techniques
Number of subjects: 37
Study: 11743835

Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 573

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 573

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 573
Study: 9288699

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 847

Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogen (CEE) 0.625 mg daily
Number of subjects: 847

Group type: EXPERIMENTAL
Intervention: CEE 0.625 daily plus medroxyprogesterone acetate (MPA) 10 mg, days 1-12
Number of subjects: 847

Group type: EXPERIMENTAL
Intervention: CEE 0.625 daily plus MPA 2.5 mg daily
Number of subjects: 847

Group type: EXPERIMENTAL
Intervention: CEE 0.625 daily plus micronized progesterone (MP) 200 mg, days 1-12
Number of subjects: 847
Study: 8323357

Group type: EXPERIMENTAL
Intervention: Nasal CPAP
Number of subjects: 120

Group type: COMPARATOR
Intervention: Headbox oxygen
Number of subjects: 120
Study: 2852252

Group type: EXPERIMENTAL
Intervention: Lisinopril, 20 to 80 mg once daily
Number of subjects: 45

Group type: COMPARATOR
Intervention: Nifedipine retard, 20 to 40 mg twice daily
Number of subjects: 45
Study: 29076387

Group type: EXPERIMENTAL
Intervention: Transcutaneous acupoint interferential current (IFC) stimulation, 14 sessions over 2 weeks
Number of subjects: 198

Group type: COMPARATOR
Intervention: Lactulose orally (control group)
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Transcutaneous acupoint interferential current (IFC) stimulation
Number of subjects: 198
Study: 27344641

Group type: EXPERIMENTAL
Intervention: Supervised moderate-to-high intensity aerobic exercise 1 hour × 3/week for 16 weeks
Number of subjects: 200
Study: 23305358

Group type: EXPERIMENTAL
Intervention: Locator (LA) attachment system
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Retentive Anchor (RA) attachment system
Number of subjects: 24
Study: 22361115

Group type: EXPERIMENTAL
Intervention: Own first-name (OWN)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Unfamiliar first-name (OTHER)
Number of subjects: 36
Study: 20110630

Group type: EXPERIMENTAL
Intervention: HP802-247 (allogeneic tissue engineering product)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 18344432

Group type: EXPERIMENTAL
Intervention: Intracoronary administration of blood‐derived circulating progenitor cells (CPCs) (69 +/- 14 x 10(6) CPCs)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo (cell‐free serum)
Number of subjects: 26
Study: 15800267

Group type: EXPERIMENTAL
Intervention: Sunscreen application (daily application)
Number of subjects: 0
Study: 12055818

Group type: EXPERIMENTAL
Intervention: Praziquantel (PZQ) chemotherapy
Number of subjects: 112
Study: 10470632

Group type: EXPERIMENTAL
Intervention: 0.7 MAC Xe with 0.6 MAC sevoflurane
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: 1 MAC Xe with 0.3 MAC sevoflurane
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: 1.3 MAC isoflurane
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: 1.3 MAC sevoflurane
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: 0.7 MAC nitrous oxide (N2O) with 0.6 MAC sevoflurane
Number of subjects: 35
Study: 8726951

Group type: EXPERIMENTAL
Intervention: mini‐Wright peak flow meter added in series with pneumotachograph
Number of subjects: 112

Group type: COMPARATOR
Intervention: pneumotachograph alone
Number of subjects: 112
Study: 1527739

Group type: EXPERIMENTAL
Intervention: Castable ceramic crowns
Number of subjects: 0

Group type: COMPARATOR
Intervention: Gold crowns
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined absolute marginal discrepancy (fit)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Variance of combined absolute marginal discrepancy (fit)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Standard deviation of crowns
Number of subjects: 0

Group type: COMPARATOR
Intervention: Individual gold crown specimens
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Individual ceramic crown specimens
Number of subjects: 0
Study: 6360300

Group type: EXPERIMENTAL
Intervention: 2000 rad in 10 daily fractions
Number of subjects: 824

Group type: EXPERIMENTAL
Intervention: 500 rad as a single fraction
Number of subjects: 824

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 824

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 824
Study: 31169562

Group type: EXPERIMENTAL
Intervention: VITOM
Number of subjects: 92

Group type: COMPARATOR
Intervention: no VITOM
Number of subjects: 92
Study: 30833068

Group type: EXPERIMENTAL
Intervention: Peginterferon alfa-2a plus TDF (300 mg once daily)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Peginterferon alfa-2a plus placebo
Number of subjects: 120
Study: 29024612

Group type: EXPERIMENTAL
Intervention: Asynchronous telepsychiatry (ATP)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Synchronous telepsychiatry (STP)
Number of subjects: 158
Study: 26777408

Group type: EXPERIMENTAL
Intervention: CuPiD system (smartphone application with positive and corrective feedback on gait)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Active control (personalized gait advice)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Both groups (CuPiD and control)
Number of subjects: 40
Study: 24246818

Group type: EXPERIMENTAL
Intervention: Aerobic exercise as an adjunct smoking cessation treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wellness contact control program
Number of subjects: 0
Study: 22081114

Group type: EXPERIMENTAL
Intervention: Longitudinal ultrasound imaging for thoracic epidural block (T5‐T6 or T6‐T7)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Usual epidural block without ultrasound (Control)
Number of subjects: 10
Study: 20802206

Group type: EXPERIMENTAL
Intervention: Deep brain stimulation ON with medication ON
Number of subjects: 13

Group type: COMPARATOR
Intervention: Deep brain stimulation OFF with medication ON
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Deep brain stimulation ON with medication OFF
Number of subjects: 13

Group type: COMPARATOR
Intervention: Deep brain stimulation OFF with medication OFF
Number of subjects: 13

Group type: COMPARATOR
Intervention: Comparison with age-matched healthy subjects
Number of subjects: 13
Study: 18254794

Group type: EXPERIMENTAL
Intervention: Biofeedback with electrical pulses (Grindcare(R)), applied through EMG electrodes with a non-painful intensity (1-7 mA) during detected jaw-clenching activity.
Number of subjects: 14

Group type: COMPARATOR
Intervention: Baseline EMG activity (no biofeedback)
Number of subjects: 14
Study: 16187513

Group type: EXPERIMENTAL
Intervention: ACL-deficient noncoper group
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 15
Study: 14515935

Group type: EXPERIMENTAL
Intervention: Home-based strength-training programme
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 21
Study: 10782658

Group type: EXPERIMENTAL
Intervention: > 0 and <= 10 g of alcohol/day
Number of subjects: 1336

Group type: EXPERIMENTAL
Intervention: > 10 and <= 20 g/day
Number of subjects: 1336

Group type: EXPERIMENTAL
Intervention: > 20 and <= 30 g/day
Number of subjects: 1336

Group type: EXPERIMENTAL
Intervention: > 30 and <= 40 g/day
Number of subjects: 1336

Group type: EXPERIMENTAL
Intervention: > 40 and <= 50 g/day
Number of subjects: 1336

Group type: EXPERIMENTAL
Intervention: > 50 g/day
Number of subjects: 1336
Study: 8873656

Group type: EXPERIMENTAL
Intervention: Accelerated tissue plasminogen activator (TPA) plus intravenous heparin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Streptokinase plus subcutaneous heparin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Streptokinase plus intravenous heparin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Streptokinase and TPA plus intravenous heparin
Number of subjects: 0
Study: 1642941

Group type: EXPERIMENTAL
Intervention: Isoflurane (0.65-0.75%)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Nitrous oxide (60-65%)
Number of subjects: 8
Study: 6342701

Group type: EXPERIMENTAL
Intervention: Ceruletide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fatty meal
Number of subjects: 0

Group type: COMPARATOR
Intervention: Solubiloptin following Biloptin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Biloptin
Number of subjects: 0
Study: 31045669

Group type: EXPERIMENTAL
Intervention: Adductor canal block and periarticular injection
Number of subjects: 111

Group type: COMPARATOR
Intervention: Periarticular injection
Number of subjects: 111
Study: 29426387

Group type: EXPERIMENTAL
Intervention: Co-PID (Collaborative Consultation for Participation of Students With Intellectual Disability)
Number of subjects: 60

Group type: COMPARATOR
Intervention: In-Service (IS)
Number of subjects: 60
Study: 27912776

Group type: EXPERIMENTAL
Intervention: Toolkit of quality improvement interventions including provider-focused strategies (education, audit and feedback, electronic decision support, reminders) and patient-directed strategies (educational letters, reminders)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not explicitly defined in the abstract)
Number of subjects: 0
Study: 24431443

Group type: EXPERIMENTAL
Intervention: EEG activity during face detection task
Number of subjects: 0
Study: 22578258

Group type: EXPERIMENTAL
Intervention: Treated threshold ROP patients (group 1)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Regressed ROP patients (group 2)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Premature patients without ROP (group 3)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Normal full-term children (group 4)
Number of subjects: 133
Study: 19047294

Group type: EXPERIMENTAL
Intervention: Standard-dose induction chemotherapy (cytarabine, daunorubicin, and 6-thioguanine)
Number of subjects: 1284

Group type: EXPERIMENTAL
Intervention: High-dose induction chemotherapy (cytarabine and mitoxantrone)
Number of subjects: 1284

Group type: COMPARATOR
Intervention: High-dose combination (two courses)
Number of subjects: 1284
Study: 17459189

Group type: EXPERIMENTAL
Intervention: Low-fat milk
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Low-fat milk with added 20 mmol/l NaCl
Number of subjects: 11

Group type: COMPARATOR
Intervention: Water
Number of subjects: 11

Group type: COMPARATOR
Intervention: Sports drink
Number of subjects: 11
Study: 16425789

Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg once daily for 6 weeks
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Fluvastatin 40 mg once daily for 6 weeks
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (12 clinically healthy subjects with no CHD risk factors)
Number of subjects: 35
Study: 12002729

Group type: EXPERIMENTAL
Intervention: 120mg Fexofenadine (FEX)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: 10mg Montelukast (ML) + 10mg Loratadine (LT)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 37
Study: 10213063

Group type: EXPERIMENTAL
Intervention: Pharyngeal flap surgery with different flap widths
Number of subjects: 53
Study: 7875470

Group type: EXPERIMENTAL
Intervention: Sympathetic activation (induced by lower body negative pressure)
Number of subjects: 9

Group type: COMPARATOR
Intervention: No sympathetic activation
Number of subjects: 9
Study: 1923171

Group type: EXPERIMENTAL
Intervention: Transdermal scopolamine
Number of subjects: 0

Group type: COMPARATOR
Intervention: No transdermal scopolamine (Control)
Number of subjects: 0
Study: 7040956

Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside infusion for 48 hours
Number of subjects: 812

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 812

Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside infusion started within nine hours of onset of pain
Number of subjects: 812

Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside infusion started later than nine hours of onset of pain
Number of subjects: 812